ONCY Market Cap History — Oncolytics Biotech Capitalization Over Time

As of 8/10/2026 Oncolytics Biotech has a market cap of 102.01 million. Investors often follow the ONCY market cap history to compare the size of the company over time.

This page shows ONCY market capitalization trends over time, with 8 market cap datapoints presented, dating back to 5/25/2018.

Quick links: Market Cap History Table  |  Market Cap History Chart  |  About Oncolytics Biotech
ONCY Market Cap History



Below is a table of the ONCY market cap history going back to 5/25/2018:

Date ONCY Market Cap
5/25/201899.94M
6/1/2018132.91M
6/30/201891.03M
12/31/201831.49M
12/31/2019153.26M
12/31/2020109.88M
5/12/2026107.42M
8/10/2026102.01M

Also see: ONCY Shares Outstanding History
and ONCY YTD Return
ONCY Historical Market Cap:
+0.25% CAGR
ONCY Historical Market Cap: +0.25% CAGR

Mouse over chart for data details
5/25/20186/1/20186/30/201812/31/201812/31/201912/31/20205/12/20268/10/2026
Oncolytics Biotech Inc. is a clinical-stage biotechnology company. Co. is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. We show 8 historical shares outstanding datapoints in our ONCY shares outstanding history coverage, used to compute ONCY market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ONCY market cap history over the course of time is important for investors interested in comparing ONCY's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ONCY versus a peer is one thing; comparing ONCY market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ONCY can fluctuate over the course of history. With this page we aim to empower investors researching ONCY by allowing them to research the ONCY market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree ONCY Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap
Oncolytics Biotech (ONCY) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ONEM Market Cap History
ONS Market Cap History
ONTX Market Cap History
ONVO Market Cap History
OPCH Market Cap History
OPGN Market Cap History
OPHT Market Cap History
OPK Market Cap History
OPNT Market Cap History
OPTN Market Cap History
More Healthcare companies »
 

ONCY Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?
⤹


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.